ڸפ±ʬ糰ʡ׾ʥåդμʶӡ
Psycho-Oncology 2012 (Article first published online:DOI: 10.1002/pon.3023)
Tsuguo Iwatani, Ayako Matsuda, Hidetaka Kawabata, Daishu Miura, Eisuke Matsushima
Predictive factors for psychological distress related to diagnosis of breast cancer.

J.Clin.Oncol 2011,29, e113-115
Tsuguo Iwatani, Hidetaka Kawabata, Daishu Miura, Yasunori Ota, Kenichi Ohashi
Complete Spontaneous Regression of Primary Diffuse Large B-cell Lymphoma of the Breast

N Engl J Med 2011;365:1056-7
Marie Hanaoka, Toshimi Takano, Hidetaka Kawabata (Comment on: N Engl J Med 2011; 364: 2381-2391)
Exemestane for Breast-Cancer Prevention.

Lancet 2011,377,121
Keisuke Shigeta, Yuji Miura,Yoichi Naito, Toshimi Takano
Cabazitaxel for castration-resistant prostate cancer

N Engl J Med 363:2371, 2010
Naito Y Miura Y Takano T (Comment on: N Engl J Med 363:943-53, 2010)
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.

N Engl J Med 361:2485-6, 2009
Takano T (Comment on: N Engl J Med 361:947-57, 2009)
Treatment of lung cancer.

Breast Cancer, 2009, DOI 10.1007/s12282-009-0149-1
Tsuguo Iwatani, Hidetaka Kawabata, Daishu Miura, Naoko Inoshita, Yasunori Ohta
Nodular fasciitis of the breast.

J Clin Oncol 27:464-465, 2009
Takano T, Ota S, Hori A, Seki N, and Eguchi K:
Can Epidermal Growth Factor Receptor?Fluorescent in Situ Hybridization Predict Clinical Benefit From Cetuximab Treatment in Patients With Non?Small-Cell Lung Cancer?

J Clin Oncol 26: 5589-5595, 2008
Takano T, Fukui T, Ohe Y, et al:
EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan.

Clin Cancer Res 13:5385-5390, 2007
Takano T, Ohe Y, Tsuta K, et al:
Epidermal Growth Factor Receptor Mutation Detection Using High-Resolution Melting Analysis Predicts Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Gefitinib.

J Clin Oncol 24:1221, 2006
Takano T, Ohe Y, Sekine I, Kunitoh H, Yoshida T, and Tamura T:
In Reply. (Reply to: J Clin Oncol 24:1219-1220, 2006)

N Engl J Med 353:1739-41, 2005
Takano T and Ohe Y:
Erlotinib in lung cancer. (Comment on: N Engl J Med 353:123-32 and 133-44, 2005)

J Clin Oncol 23:6829-37, 2005
Takano T, Ohe Y, Sakamoto H, et al:
Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer.

Lancet,2001,358,1018
Hidetaka Kawabata, Takafumi Ueno
Screening recommendation for women taking tamoxifen

Lancet 2000,355,238
Takafumi UenoHidetaka Kawabata
Tobacco and health care professionals in Japan

Lancet 1999,354,1207
Hidetaka KawabataTakafumi Ueno
Early Lung Cancer Action Project.

Lancet 1999,353,2077
Hidetaka KawabataTakafumi Ueno
Controversy over cancer chemotherapy in Japan



ȥåץڡ: